Related Experiment Videos
Hyperlipidaemia in renal transplant patients
S Aakhus1, K Dahl, T E Widerøe
1Department of Medicine, University Hospital of Trondheim, Norway.
Journal of Internal Medicine
|May 1, 1996
Summary
Hyperlipidaemia is common in renal transplant recipients, with higher cholesterol levels than the general population. It is linked to poorer graft function and hypertension, but not cyclosporine use.
Area of Science:
- Nephrology
- Cardiology
- Pharmacology
Background:
- Hyperlipidaemia is a significant complication following renal transplantation.
- Understanding its prevalence and associated factors is crucial for patient management.
Purpose of the Study:
- To determine the prevalence and severity of hyperlipidaemia in renal transplant patients in a Nordic country.
- To investigate the relationship between blood lipid levels and clinical parameters.
Main Methods:
- A multicentre, cross-sectional study involving 406 renal transplant patients with functioning grafts.
- Data collected on blood lipids, clinical parameters, and immunosuppressive medications (prednisolone, cyclosporine, azathioprine).
- Comparison of lipid levels with a national survey of the general population.
Main Results:
- Renal transplant patients exhibited significantly higher total cholesterol than the general population.
- Female patients had higher total and HDL cholesterol levels; 33% had elevated triglycerides.
- Independent factors associated with higher total cholesterol included reduced creatinine clearance, high BMI, female gender, hypertension, and coronary artery disease.
Conclusions:
- Hyperlipidaemia is highly prevalent post-renal transplantation.
- Impaired graft function, hypertension, and use of beta-blockers and diuretics are associated with hyperlipidaemia.
- Cyclosporine immunosuppression was not found to be associated with blood lipid levels.